Conference Coverage ACC 2024 See All Content See past conferences Atlanta, Georgia April 06, 2024 April 08, 2024 News Conference News ACC 2024 KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives Effects were more marked for patients already taking a diuretic or calcium channel blocker, but less so on top of a potent ARB. More News News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024 News Conference News ACC 2024 BE ACTIVE: Gaming for Points and Money Can Boost Step Counts L.A. McKeown April 11, 2024 News Conference News ACC 2024 IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease Caitlin E. Cox April 10, 2024 News Conference News ACC 2024 ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI Yael L. Maxwell April 07, 2024 News Conference News ACC 2024 Need a Statin for Primary Prevention? There’s an App for That Michael O'Riordan April 10, 2024 More Slides Presentation ACC 2024 Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial Presenter: David E. Kandzari April 08, 2024 Presentation ACC 2024 Primary Results from the Phase 2 KARDIA-2 Study Presenter: Akshay Desai April 07, 2024 Presentation ACC 2024 Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock Presenter: Jacob Eifer Møller April 07, 2024 Presentation ACC 2024 PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques Presenter: Seung-Jung Park April 07, 2024 Presentation ACC 2024 Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease Presenter: Young-Guk Ko April 08, 2024
News Conference News ACC 2024 KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives Effects were more marked for patients already taking a diuretic or calcium channel blocker, but less so on top of a potent ARB.
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News ACC 2024 BE ACTIVE: Gaming for Points and Money Can Boost Step Counts L.A. McKeown April 11, 2024
News Conference News ACC 2024 IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease Caitlin E. Cox April 10, 2024
News Conference News ACC 2024 ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI Yael L. Maxwell April 07, 2024
News Conference News ACC 2024 Need a Statin for Primary Prevention? There’s an App for That Michael O'Riordan April 10, 2024
Presentation ACC 2024 Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial Presenter: David E. Kandzari April 08, 2024
Presentation ACC 2024 Primary Results from the Phase 2 KARDIA-2 Study Presenter: Akshay Desai April 07, 2024
Presentation ACC 2024 Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock Presenter: Jacob Eifer Møller April 07, 2024
Presentation ACC 2024 PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques Presenter: Seung-Jung Park April 07, 2024
Presentation ACC 2024 Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease Presenter: Young-Guk Ko April 08, 2024